Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00520065 · ClinicalTrials.gov registry record · Phase 2
Comparison of Nutritional Products for People With Type 2 Diabetes
A Phase 2 study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- Phase 2
- Development phase
- 33
- Enrollment target
NCT00520065: Completed Phase 2 study, sponsored by Abbott Nutrition.
NCT00520065 is a Phase 2 study that has completed, run by Abbott Nutrition. The registered enrollment target is 33 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00520065, a Phase 2 study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 33 participants
- Enrollment target
Study Summary
Part A: To compare the glucose and insulin responses of a standard tube feeding product to that of a diabetes-specific tube feeding product in individuals with type 2 diabetes. Part B: To compare the glucose response of a standard tube feeding product to that of a diabetes-specific tube feeding product when consumed by individuals with type 2 diabetes as a sole source of nutrition.
Interventions
- OTHER enteral nutritional formula
- OTHER Diabetes specific enteral product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2007-08 |
| Est. Completion | 2007-11 |
| Phase | Phase 2 |
What the finished NCT00520065 record still lists
NCT00520065 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 2 interventions - of which enteral nutritional formula is the first listed.
NCT00520065 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00520065 about?
NCT00520065 is a clinical study titled "Comparison of Nutritional Products for People With Type 2 Diabetes". Part A: To compare the glucose and insulin responses of a standard tube feeding product to that of a diabetes-specific tube feeding product in individuals with type 2 diabetes. Part B: To compare the glucose response of a standard tube feeding product to that of a diabetes-specific tube feeding pro...
What is the current status of trial NCT00520065?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 33 participants. The study started on 2007-08. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00520065?
The interventions under investigation include: enteral nutritional formula (OTHER), Diabetes specific enteral product (OTHER).
Who is sponsoring clinical trial NCT00520065?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00520065's enrollment target sits among peer trials
33 1553rd of 2000 higher than 438 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia